Sangamides, a new class of cyclophilin-inhibiting host-targeted antivirals for treatment of HCV infection

Philippe Gallay, Barrie Wilkinson, Matthew A. Gregory, Steven J. Moss, Michael Bobardt, Pieter Leyssen, Nigel Coates, Udayan Chatterji, Xie Dejian, Teresa Foster, Jinlun Liu, Mohammad Nur-e-Alam, Dipen Suthar, Chen Yongsheng, Tony Warneck, Ming-Qiang Zhang, Johan Neyts
  • MedChemComm, January 2012, Royal Society of Chemistry
  • DOI: 10.1039/c1md00227a
The author haven't yet claimed this publicationThe author haven't yet claimed this publication